Back to directory

center TTR-amyloidosis

Pirogov Russian National Research Medical University

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 1 Rare Subtype

Contact Information

Primary Contact

Eruslanova Kseniia

Head of the Laboratory of Cardiovascular Aging

Activity level

  • Patients per year40
  • New diagnoses per year30

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyThrough formal referral
Other specialists
GastroenterologyPrimary CareRheumatologyOrthopaedicsNuclear medicine specialistsCardiac imaging specialistsRadiologistsPsychology / counsellingSocial work

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingThrough network partners
  • Histopathology (Congo red)Through network partners
  • Amyloid typingThrough network partners
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site
Partner laboratories

BUYANOV MOSCOW CITY HOSPITAL (Histopathology with Congo red strain, amyloid typing)
National medical research center pf cardiology named after Chazov E.I. (Radionuclide imaging)

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Localised amyloidosis
Referral pathways

One patient with localized amyloidosis managed with neurosurgeon center.

Treatment options

  • Chemotherapy (AL)Available via formal referral
  • TTR stabilizersAvailable via formal referral
  • RNA interferenceNot available
  • Antisense oligonucleotidesAvailable via formal referral
  • Stem cell transplantAvailable via formal referral
  • Heart transplantAvailable via formal referral
  • Kidney transplantAvailable via formal referral
  • Liver transplantAvailable via formal referral

Patient support services

Services offered
Psychosocial supportSocial workNutritional guidance (dietitian)Specialty pharmacyFinancial or access counselling

Networks & telemedicine

  • Telemedicine / virtual consultationYes
  • Part of a formal amyloidosis networkYes
  • Diagnostic services for other organisationsYes

Last confirmed: 30 April 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.